Maravai LifeSciences Holdings, Inc. Derivative Asset
Maravai LifeSciences Holdings, Inc. (MRVI) had Derivative Asset of $1.38 million as of 2024-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-02-26
- 2024-12-31: Derivative Asset $1.38M.
- 2023-12-31: Derivative Asset $427.24M.
- 2023-09-30: Derivative Asset $438.63M.
- 2023-06-30: Derivative Asset $340.39M.
| Period end | Derivative Asset |
|---|---|
| 2024-12-31 | $1.38M 10-K · filed 2026-02-26 |
| 2023-12-31 | $427.24M 10-K · filed 2024-02-29 |
| 2023-09-30 | $438.63M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $340.39M 10-Q · filed 2023-08-08 |